Skip to content

Effectiveness of m-CIMT of the Upper Limb in Acute Post-stroke Patients. (m-CIMT, Modified Constraint-induced Movement Therapy)

Effectiveness of m-CIMT of the Upper Limb in Acute Post-stroke Patients.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07233161
Acronym
m-CIMT
Enrollment
66
Registered
2025-11-18
Start date
2025-04-23
Completion date
2026-12-20
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Isquemic Stroke, Upper Limb Weakness Due to Central Neurologic Injury

Keywords

m-CIMT, stroke, upper limb weakness, upper limb

Brief summary

m-CIMT therapy is the restriction of the unaffected upper extremity in conjunction with an upper extremity specific exercise protocol to improve the functionality and use of the affected upper extremity.

Detailed description

The study consists of a total of 7 days with a total of 3 hours per day of restraint of the unaffected upper limb together with 1 physiotherapy session per day specific to the affected upper limb.

Interventions

BEHAVIORALm-CIMT

m-CIMT therapy (healthy side restraint) and a specific upper limb exercise protocol.

Sponsors

Hospital Clinic of Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomised, single-centre, single-blind, prospective, prospective clinical trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ischaemic stroke. * Hospitalised patient (first 15 days). * Ability to understand and execute simple instructions. * Over 18 years of age. * Upper limb motor deficit. * Sign the informed consent document.

Exclusion criteria

* Unstable clinical/medical condition. * Limitation of the upper limb due to a previous stroke. * Strokes affecting both upper limbs bilaterally. * Fractures/dislocations in the joints of the affected upper limb that may affect recovery. * Severe behavioural disturbance.

Design outcomes

Primary

MeasureTime frameDescription
AbilhandBasal, immediately after the intervention, 3 months after treatmentThe ABILHAND assesses a person's ability to perform manual activities of daily living. It is based on the patient's perception of the difficulty of these tasks. It is a tool for measuring activity. This scale is scored from 0 to 46 with 46 being the best score.
Fatigue Assessment Scale (FAS)Basal, immediately after the intervention, 3 months after treatmentThe Fatigue Assessment Scale (FAS) is a questionnaire that assesses the level of physical and mental fatigue in patients with various health conditions. It consists of 10 items that the patient answers according to their recent experience. This scale has two scores: Mental fatigue from 0 to 25 (sum of items 3, 6, 7, 8 and 9) and physical fatigue from 0 to 25 (sum of items 1, 2, 4, 5 and 10). With 25 being the worst score for both cases.
Stroke Impact ScaleBasal,immediately after the intervention, 3 months after treatmentThe Stroke Impact Scale (SIS) assesses the difficulty a person has in performing daily activities during the last two weeks after a stroke. The minimum score on this scale is 16 points and the maximum is 80 points, with 80 being the best score.
Fugl-MeyerBasal, immediately after the intervention, 3 months after treatmentThe Fugl-Meyer Upper Extremity Scale assesses motor function of the arm and hand after stroke. It measures movements, reflexes and coordination, with a maximum score of 66. It is a structure-measuring tool. This scale is scored from 0 to 66 with 66 being the best score.
Motor Activity Log3 months after treatmentThe Motor Activity Log (MAL) assesses how much and how well a person uses their affected arm in everyday activities after a stroke. It is based on interviews and rates the Amount of Use and Quality of Movement of the use of the paretic arm in daily life. This scale has two scores, quality and quantity. From 0 to 150 for quantity and from 0 to 150 for quality. 150 being the best result in both cases.

Secondary

MeasureTime frameDescription
National Institutes of Health Stroke Scale (NIHSS)Basal, immediately after the intervention, 3 months after treatmentThe NIHSS (National Institutes of Health Stroke Scale) is a clinical scale that assesses the severity of stroke. It measures functions such as level of consciousness, language, vision, vision, strength, sensation and coordination. This scale is scored from 0 to 42 with 42 being the worst score.
Modified Rankin Scale (MRS)Basal, immediately after the intervention, 3 months after treatmentThe modified Rankin Scale (MRS) assesses the degree of disability or dependence in daily activities after a stroke. It ranges from 0 (no symptoms) to 6 (death). The minimum score is 0 and the maximum score is 5 points. The worst score is 5 points.

Countries

Spain

Contacts

Primary ContactMaria S Suarez, Fisioterapia
suarezi@clinic.cat+34689409432
Backup ContactInes G Garcia, Fisioterapia
+34665538737

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026